Report Categories
View AllRecent Articles
View All
What Is The Price Target For Fate Therapeutics Fate Stock Fate Q4 2025 Earnings Fate Therapeutics Inc. Posts Narrow Eps Beat No Revenue Reported 20260410 1
EVC Q1 2026 Earnings EPS of 013 Reported Stock Declines 11 on Limited Disclosures
FCX Q1 2026 Earnings Copper Producer Beats EPS Estimates by Wide Margin Amid Operational Gains
CAPL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies
ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance
AFB Q3 2024 Earnings Solid Net Investment Income Amid Stable Municipal Bond Market
Palladyne AI Warrants Hold Steady Near 004 Amid LowVolume Trading
Universal Corporation UVV Edges Higher as Price Nears Key Support
Hovnanian Enterprises HOV Climbs 24 as Housing Sector Momentum Builds
Primo Brands PRMB Shows Strength with 229 Gain Approaches Key Resistance